MEDS Earnings: Highlights of Trxade Health’s Q2 2023 financial results

Trxade Q2 2023 earnings infographic


Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a decrease in revenues for the second quarter of fiscal 2023. The company’s net loss widened from the prior-year quarter.

Trxade Q2 2023 earnings infographic

Revenues decreased 31% from last year to $2.25 million in the second quarter. The decline mainly reflects weak performance by the Integra subsidiary.

Net loss attributable to Trxade Health was $1.97 million or $2.90 per share in Q2, compared to a loss of $1.08 million or $1.99 per share in the same period of last year.

The TRxADE platform increased its registered users by 1,149 or 8% as of June 30, 2023, compared to June 30, 2022. For the six months ended June 30, new registrations were 291, compared to 339 a year earlier. At the end of the quarter, the company had total registered users of around 4,100+, compared to 12,962 last year.

Prior Performance

Leave a Reply

Your email address will not be published. Required fields are marked *